Azadeh Stark

2.8k total citations
64 papers, 2.0k citations indexed

About

Azadeh Stark is a scholar working on Oncology, Cancer Research and General Health Professions. According to data from OpenAlex, Azadeh Stark has authored 64 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 23 papers in Cancer Research and 11 papers in General Health Professions. Recurrent topics in Azadeh Stark's work include Breast Cancer Treatment Studies (17 papers), Global Cancer Incidence and Screening (13 papers) and HER2/EGFR in Cancer Research (7 papers). Azadeh Stark is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), Global Cancer Incidence and Screening (13 papers) and HER2/EGFR in Cancer Research (7 papers). Azadeh Stark collaborates with scholars based in United States, China and Thailand. Azadeh Stark's co-authors include Barbara S. Hulka, Jennifer J. Griggs, Andrew W. Dick, Melony E. Sorbero, Richard J. Zarbo, Brian J. Zikmund‐Fisher, Peter A. Ubel, Angela Fagerlin, Jennifer B. McClure and Dylan Smith and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Azadeh Stark

60 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Azadeh Stark United States 23 877 499 321 283 207 64 2.0k
Kepher H. Makambi United States 31 877 1.0× 446 0.9× 284 0.9× 445 1.6× 184 0.9× 95 2.4k
Judith Hurley United States 24 1.1k 1.2× 646 1.3× 256 0.8× 219 0.8× 150 0.7× 74 2.3k
DeAnn Lazovich United States 31 1.2k 1.3× 350 0.7× 296 0.9× 258 0.9× 181 0.9× 88 3.4k
Nirmala Bhoo‐Pathy Malaysia 25 1.1k 1.3× 604 1.2× 145 0.5× 174 0.6× 301 1.5× 113 2.0k
John H. Ward United States 29 588 0.7× 275 0.6× 410 1.3× 299 1.1× 291 1.4× 74 2.3k
Lauren Clarke United States 15 1.6k 1.9× 692 1.4× 368 1.1× 233 0.8× 458 2.2× 32 2.6k
Carlos H. Bárcenas United States 26 1.0k 1.2× 767 1.5× 255 0.8× 268 0.9× 327 1.6× 106 2.1k
Amyé Tevaarwerk United States 25 1.2k 1.4× 425 0.9× 272 0.8× 508 1.8× 441 2.1× 102 2.2k
Lei Fan China 19 935 1.1× 622 1.2× 217 0.7× 602 2.1× 249 1.2× 57 2.2k
Kirstin Pirie United Kingdom 25 1.2k 1.4× 400 0.8× 235 0.7× 457 1.6× 302 1.5× 36 3.1k

Countries citing papers authored by Azadeh Stark

Since Specialization
Citations

This map shows the geographic impact of Azadeh Stark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azadeh Stark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azadeh Stark more than expected).

Fields of papers citing papers by Azadeh Stark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azadeh Stark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azadeh Stark. The network helps show where Azadeh Stark may publish in the future.

Co-authorship network of co-authors of Azadeh Stark

This figure shows the co-authorship network connecting the top 25 collaborators of Azadeh Stark. A scholar is included among the top collaborators of Azadeh Stark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azadeh Stark. Azadeh Stark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rohan, Thomas E., Fergus J. Couch, Robert T. Greenlee, et al.. (2025). p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 34(6). 1036–1039.
2.
Cao, Mingguo, et al.. (2024). Nurses’ Workplace Social Capital and Sustainable Development: An Integrative Review of Empirical Studies. Journal of Nursing Management. 2024(1). 8362035–8362035. 2 indexed citations
3.
4.
Giordo, Roberta, Erica L. Kleinbrink, Lawrence I. Grossman, et al.. (2023). Non-coding regions of nuclear-DNA-encoded mitochondrial genes and intergenic sequences are targeted by autoantibodies in breast cancer. Frontiers in Genetics. 13. 970619–970619. 1 indexed citations
5.
Stark, Azadeh, et al.. (2021). A conceptual model of nurses’ workplace social capital: a theory synthesis. BMC Nursing. 20(1). 148–148. 11 indexed citations
6.
Mehdorn, H. Maximilian, et al.. (2018). The programmable shunt-system Codman Medos Hakim: A clinical observation study and review of literature. Clinical Neurology and Neurosurgery. 173. 154–158. 6 indexed citations
7.
Rutter, Carolyn M., Robert T. Greenlee, Eric Johnson, et al.. (2015). Prevalence of colonoscopy before age 50. Preventive Medicine. 72. 126–129. 7 indexed citations
8.
Weinmann, Sheila, Andrew E. Williams, Aruna Kamineni, et al.. (2015). Cervical cancer screening and follow‐up in 4 geographically diverse US health care systems, 1998 through 2007. Cancer. 121(17). 2976–2983. 9 indexed citations
10.
Dillard, Amanda J., Laura D. Scherer, Peter A. Ubel, et al.. (2012). Breast cancer anxiety's associations with responses to a chemoprevention decision aid. Social Science & Medicine. 77. 13–19. 20 indexed citations
11.
Hayes, Sandra C., et al.. (2011). Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial. Breast Cancer Research and Treatment. 130(1). 227–234. 32 indexed citations
12.
Stark, Azadeh, Celina G. Kleer, Iman K. Martin, et al.. (2010). African ancestry and higher prevalence of triple‐negative breast cancer. Cancer. 116(21). 4926–4932. 176 indexed citations
13.
Stark, Azadeh, Daniel Schultz, Alissa Kapke, et al.. (2009). Obesity and risk of the less commonly diagnosed subtypes of breast cancer. European Journal of Surgical Oncology. 35(9). 928–935. 14 indexed citations
14.
Stark, Azadeh, et al.. (2008). Human papillomavirus, cervical cancer and women's knowledge. Cancer Detection and Prevention. 32(1). 15–22. 45 indexed citations
15.
Zikmund‐Fisher, Brian J., Peter A. Ubel, Dylan Smith, et al.. (2008). Communicating side effect risks in a tamoxifen prophylaxis decision aid: The debiasing influence of pictographs. Patient Education and Counseling. 73(2). 209–214. 137 indexed citations
17.
Carlson, Robert W., Susan J. Moench, M. Elizabeth H. Hammond, et al.. (2006). HER2 Testing in Breast Cancer: NCCN Task Force Report and Recommendations. Journal of the National Comprehensive Cancer Network. 4(S3). S–1. 150 indexed citations
18.
Stark, Azadeh, Edward L. Peterson, Gene X. Kortsha, et al.. (2006). Whole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease. Environmental Health Perspectives. 114(12). 1872–1876. 141 indexed citations
19.
Stark, Azadeh, et al.. (2002). Evaluating Post‐Treatment Screening in Women with Breast Cancer. Cancer Practice. 10(5). 228–233.
20.
Stark, Azadeh, Barbara S. Hulka, Debra B. Novotny, et al.. (2000). HER-2/neu Amplification in Benign Breast Disease and the Risk of Subsequent Breast Cancer. Journal of Clinical Oncology. 18(2). 267–267. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026